Dec 12 (Reuters) – The European Medicines Agency’s committee on Friday recommended a change to extend the use of Eli Lilly’s blockbuster drug Mounjaro for the treatment of type 2 diabetes in adolescents and children from 10 years of age. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
Health
EMA committee recommends extending use of Lilly’s diabetes drug to children
Audio By Carbonatix
Dec 12 (Reuters) – The European Medicines Agency’s committee on Friday recommended a change to extend the use of Eli Lilly’s blockbuster drug Mounjaro for the treatment of type 2 diabetes in adolescents and children from 10 years of age.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)